Patents by Inventor Byeong-Woo Park
Byeong-Woo Park has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20240133519Abstract: A liquefied gas storage tank includes a corner block disposed on a corner portion, wherein the corner block includes a lower block, an upper block and an upper connecting block, the upper block includes a first inner fixing unit and a second inner fixing unit respectively provided inside a first surface and a second surface, bonded and connected to a secondary barrier, and each having a structure in which a primary inner plywood, a primary corner insulating material, and a primary outer plywood are stacked, and an inner bent portion installed at a corner spatial portion between the first inner fixing unit and the second inner fixing unit, and both side surfaces of the inner bent portion that are perpendicular to the secondary barrier each have a height reduced from a total height of each of the first and second inner fixing units.Type: ApplicationFiled: December 14, 2021Publication date: April 25, 2024Inventors: Won Seok HEO, Seong Bo PARK, Hye Min CHO, Ki Joong KIM, Cheon Jin PARK, Min Kyu PARK, Jung Kyu PARK, Byeong Jin JEONG, Dong Woo KIM, Sung Kyu HONG, Gwang Soo GO, Jee Yeon HEO
-
Patent number: 11938247Abstract: Provided are a method for fabricating a human nasal turbinate-derived mesenchymal stem cell-based 3D bioprinted construct, and a use thereof, wherein the human nasal turbinate-derived mesenchymal stem cell-based, 3D bioprinted construct is advantageous over conventional mesenchymal stem cell-based, 3D bioprinted constructs in that the former can survive and proliferate stably in vitro and/or in vivo and shows high osteogenic differentiation ability as well, therefore is expected to make a great contribution to the practical use of cellular therapeutic agents.Type: GrantFiled: May 2, 2018Date of Patent: March 26, 2024Assignee: CATHOLIC UNIVERSITY INDUSTRY ACADEMIC COOPERATION FOUNDATIONInventors: Sung Won Kim, Jung Yeon Lim, Sun Hwa Park, Byeong Gon Yoon, Dong-Woo Cho, Jinah Jang, Seok Won Kim
-
Publication number: 20240084969Abstract: The liquefied gas storage tank includes a primary barrier, a primary insulation wall, a secondary barrier, and a secondary insulation wall. In a state where unit elements are arranged adjacent to each other, each of the unit elements being formed by stacking the secondary insulation wall, the secondary barrier, and a fixed insulation wall which is a part of the primary insulation wall, the primary insulation wall may comprise: a connection insulation wall provided in the space between the adjacent fixed insulation walls; first slits formed between the fixed insulation walls and the connection insulation wall when the connection insulation wall is inserted and installed between the adjacent fixed insulation walls; a plurality of second slits formed in a lengthwise direction and a widthwise direction of the fixed insulation walls; and a first insulating filler material for filling the first slits.Type: ApplicationFiled: December 15, 2021Publication date: March 14, 2024Inventors: Seong Bo PARK, Won Seok HEO, Hye Min CHO, Ki Joong KIM, Cheon Jin PARK, Min Kyu PARK, Jung Kyu PARK, Byeong Jin JEONG, Dong Woo KIM, Sung Kyu HONG, Gwang Soo GO, Jee Yeon HEO
-
Publication number: 20170355778Abstract: Methods of treating an individual who has an erbB protein mediated tumor is disclosed. Methods of preventing erbB protein mediated tumors in an individual are disclosed. The methods comprise administering to the individual a nucleic acid molecule that encodes a protein that dimerizes with an erbB protein and that is deficient in tyrosine kinase activity. Composition that comprise such nucleic acid molecules including pharmaceutical compositions are disclosed.Type: ApplicationFiled: February 1, 2017Publication date: December 14, 2017Applicant: The Trustees of the University of PennsylvaniaInventors: Mark I. GREENE, Donald M. O'ROURKE, Ramachandran MURALI, Byeong Woo PARK
-
Publication number: 20160289334Abstract: Methods of treating an individual who has an erbB protein mediated tumor is disclosed. Methods of preventing erbB protein mediated tumors in an individual are disclosed. The methods comprise administering to the individual a nucleic acid molecule that encodes a protein that dimerizes with an erbB protein and that is deficient in tyrosine kinase activity. Composition that comprise such nucleic acid molecules including pharmaceutical compositions are disclosed.Type: ApplicationFiled: June 3, 2015Publication date: October 6, 2016Applicant: The Trustees of the University of PennsylvaniaInventors: Mark I. Greene, Donald M. O'Rourke, Ramachandran Murali, Byeong Woo Park
-
Publication number: 20160083478Abstract: Methods of treating an individual who has an erbB protein mediated tumor is disclosed. Methods of preventing erbB protein mediated tumors in an individual are disclosed. The methods comprise administering to the individual a nucleic acid molecule that encodes a protein that dimerizes with an erbB protein and that is deficient in tyrosine kinase activity. Composition that comprise such nucleic acid molecules including pharmaceutical compositions are disclosed.Type: ApplicationFiled: June 3, 2015Publication date: March 24, 2016Applicant: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAInventors: Mark I. Greene, Donald M. O'Rourke, Ramachandran Murali, Byeong Woo Park
-
Publication number: 20150010551Abstract: Methods of treating an individual who has an erbB protein mediated tumor is disclosed. Methods of preventing erbB protein mediated tumors in an individual are disclosed. The methods comprise administering to the individual a nucleic acid molecule that encodes a protein that dimerizes with an erbB protein and that is deficient in tyrosine kinase activity. Composition that comprise such nucleic acid molecules including pharmaceutical compositions are disclosed.Type: ApplicationFiled: September 12, 2014Publication date: January 8, 2015Applicant: THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIAInventors: Mark I. Greene, Donald M. O'Rourke, Ramachandran Murali, Byeong Woo Park
-
Publication number: 20120014965Abstract: Methods of treating an individual who has an erbB protein mediated tumor is disclosed. Methods of preventing erbB protein mediated tumors in an individual are disclosed. The methods comprise administering to the individual a nucleic acid molecule that encodes a protein that dimerizes with an erbB protein and that is deficient in tyrosine kinase activity. Composition that comprise such nucleic acid molecules including pharmaceutical compositions are disclosed.Type: ApplicationFiled: April 5, 2011Publication date: January 19, 2012Inventors: Mark I. Greene, Donald M. O'Rourke, Ramachandran Murali, Byeong Woo Park
-
Patent number: 7625558Abstract: Methods of treating an individual who has an erbB protein mediated tumor is disclosed. Methods of preventing erbB protein mediated tumors in an individual are disclosed. The methods comprise adminstering to the individual a nucleic acid molecule that encodes a protein that dimerizes with an erbB protein and that is deficient in tyrosine kinase activity. Composition that comprise such nucleic acid molecules including pharmaceutical compositions are disclosed.Type: GrantFiled: March 19, 2002Date of Patent: December 1, 2009Assignee: The Trustees of the University of PennsylvaniaInventors: Mark I. Greene, Donald M. O'Rourke, Ramachandran Murali, Byeong-Woo Park
-
Publication number: 20090010935Abstract: Methods of treating an individual who has an erbB protein mediated tumor is disclosed. Methods of preventing erbB protein mediated tumors in an individual are disclosed. The methods comprise administering to the individual a nucleic acid molecule that encodes a protein that dimerizes with an erbB protein and that is deficient in tyrosine kinase activity. Composition that comprise such nucleic acid molecules including pharmaceutical compositions are disclosed.Type: ApplicationFiled: May 2, 2008Publication date: January 8, 2009Inventors: Mark I. Greene, Donald M. O'Rourke, Ramachandran Murali, Byeong-Woo Park
-
Publication number: 20020165193Abstract: Methods of treating an individual who has an erbB protein mediated tumor is disclosed. Methods of preventing erbB protein mediated tumors in an individual are disclosed. The methods comprise adminstering to the individual a nucleic acid molecule that encodes a protein that dimerizes with an erbB protein and that is deficient in tyrosine kinase activity. Composition that comprise such nucleic acid molecules including pharmaceutical compositions are disclosed.Type: ApplicationFiled: March 19, 2002Publication date: November 7, 2002Inventors: Mark I. Greene, Donald M. O'Rourke, Ramachandran Murali, Byeong-Woo Park
-
Patent number: 6417168Abstract: Methods of treating an individual who has an erbB protein mediated tumor is disclosed. Methods of preventing erbB protein mediated tumors in an individual are disclosed. The methods comprise administering to the individual a nucleic acid molecule that encodes a protein that dimerizes with an erbB protein and that is deficient in tyrosine kinase activity. Composition that comprise such nucleic acid molecules including pharmaceutical compositions are disclosed.Type: GrantFiled: July 8, 1998Date of Patent: July 9, 2002Assignee: The Trustees of the University of PennsylvaniaInventors: Mark I. Greene, Donald M. O'Rourke, Ramachandran Murali, Byeong-Woo Park